Immunai

Immunai maps the immune system at scale to facilitate the development of immune-related therapeutics for pharmaceutical companies and research institutions. The company utilizes a multiomic data platform and a large immune-focused single-cell database to provide target discovery, preclinical evaluation, and clinical trial optimization. Its workflow combines wet lab data generation with machine learning to identify drug mechanisms of action and patient populations for clinical success.